A version of this article originally appeared on Medscape.com.
Related Articles
![1]()
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
October 20, 2020
Findings suggest in part that hospitalized COVID-19 patients need aggressive treatment of hyperglycemia, regardless of the diagnosis of diabetes or A1c value.
Further warning on SGLT2 inhibitor use and DKA risk in COVID-19
October 20, 2020
Five new cases of euglycemic diabetic ketoacidosis seen in T2D patients with acute COVID-19 illness.
Guidance covers glycemia in dexamethasone-treated COVID-19 patients
October 20, 2020
The latest document from the COVID-19 response group of the Association of British Clinical Diabetologists is a response to the recent RECOVERY trial.
Hyperglycemia predicts COVID-19 death even without diabetes
October 20, 2020
This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.